Mark Lovern

22 papers receiving 539 citations

Peers

Mark Lovern
Comparison fields: 5 of 69
  • Internal Medicine 25
  • Molecular Medicine 54
  • Pharmacology 104
  • Genetics 41
  • Pharmacology 37
Replace Jian Ping Gu with:
Jian Ping Gu China
Helen S. Pentikis United States
Kiyoshi Konno Japan
Ahmed El‐Tahtawy United States
Evangelia Vlachodimitropoulou United Kingdom
Venkateswaran C. Pillai United States
Marco Dionisi Italy
Ashit Trivedi United States
Young-Joo Cho South Korea
Rosa F. Yeh United States
Mark Lovern relative to Jian Ping Gu China Jian Ping Gu's profile →
Citations per field
00.5×10×20×27×
Jian Ping Gu · 1×
Citations per year

Countries citing papers authored by Mark Lovern

Since Specialization
Citations

This map shows the geographic impact of Mark Lovern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lovern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lovern more than expected).

Fields of papers citing papers by Mark Lovern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lovern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lovern. The network helps show where Mark Lovern may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Lovern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Lovern Line = papers co-authored together Mark Lovern links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201884
2 202183
3 199750
4 200949
5 200247
6 202247
7 202137
8 200136
9 201129
10 202027
11 202125
12 199918
13 202312
14 20095
15 20225
16 20143
17 20173
18 20233
19 20192
20 20101

About Mark Lovern

Mark Lovern is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology, Pharmacology, Hematology and Infectious Diseases, having authored 23 papers that have together received 568 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Pharmacogenetics and Drug Metabolism (3 papers), Influenza Virus Research Studies (2 papers), HIV/AIDS drug development and treatment (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Chronic Myeloid Leukemia Treatments (1 paper) and Hemophilia Treatment and Research (1 paper). The work is most often cited by research in Internal Medicine (25 citations), Molecular Medicine (54 citations), Pharmacology (104 citations), Genetics (41 citations) and Pharmacology (37 citations). Mark Lovern has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Todd A. Riccobene, Timothy J. Carrothers, Paul M. Schlosser, Shampa Das, Mats O. Karlsson, Naab Al‐Saady, Norman E. Lepor, Xiaohui Wang, Constance Cullen and B. Alexander Yi. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Carcinogenesis, Antimicrobial Agents and Chemotherapy, Journal of the American Academy of Dermatology and Journal of Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact